| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 07/21/2004 | CN1514832A Process for producing soluble isoflavone-containing composition |
| 07/21/2004 | CN1514829A Novel herbicides |
| 07/21/2004 | CN1158275C Method of preparing delta-9-tetrahydrocannabinol esters |
| 07/21/2004 | CN1158274C Benzopyran-containing compounds and method for their use |
| 07/21/2004 | CN1158273C Method of extracting soybean isoflavone |
| 07/21/2004 | CN1158272C Substituted benzodihydropyranyl sulfonylurea, its preparation, use in medicines and medicines containing the same |
| 07/20/2004 | US6764993 Use of o-vanillin and o-vanillin/trolox combinations |
| 07/20/2004 | CA2267153C Synthesis of aryl ethers, methods and reagents related thereto |
| 07/15/2004 | WO2004058738A1 Total synthesis of daurichromenic acid |
| 07/15/2004 | WO2004058682A1 Selective estrogen receptor modulators |
| 07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | WO2004033390A3 Methods of preparing tocopherol compound salts in supercritical media |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | US20040138479 Protecting hydroxy with acetic acid by esterification and purification by crystalization then dissolving |
| 07/15/2004 | US20040138478 Methods of preparing tocopherol compound salts in supercritical media |
| 07/15/2004 | US20040138301 Chemical uncouplers for the treatment of obesity |
| 07/15/2004 | US20040138293 Pharmaceutical composition made of cannabis extracts |
| 07/15/2004 | US20040138266 Reacting 2-aminomethylchromam with ( 4-fluoropyriyl) pyridine-3-carbaldehyde |
| 07/15/2004 | US20040138223 Novel amide derivatives and medicinal use thereof ugs |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | US20040138183 Bactericides; anticarcinogenic agents; modulation of gene expression; therapy for antibiotic resistant bacteria |
| 07/15/2004 | DE10132936B4 Verwendung galloylierter Proanthocyanidin Use galloylierter proanthocyanidin |
| 07/15/2004 | CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435941A2 Wortmannin analogs and methods of using same |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1214309B8 Preparing amidines derived from 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid |
| 07/14/2004 | CN1513176A Optical data carrier that contains triazycyanine dye as light-absorbing compound in the information layer |
| 07/14/2004 | CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer |
| 07/14/2004 | CN1513174A Optical data carrier containing axially substituted co-phthalocynine in the information layer that can be written with light |
| 07/14/2004 | CN1513173A Optical data carrier containing a cyclizable compound in the information layer |
| 07/14/2004 | CN1513172A An optica data storage medium containing diaze hemicyanine dye as light-absorbing compound in infomration layer |
| 07/14/2004 | CN1513171A Optical data carrier containing dye in the information layer as light-absorbing compound |
| 07/14/2004 | CN1512882A Reconstitutable parenteral composition containing COX-2 inhibitor |
| 07/14/2004 | CN1511583A Chinese rose extract and its preparing method and use |
| 07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |
| 07/14/2004 | CN1157401C Neotoralactone, its derivatives and their application in reducing fat and lossing weight |
| 07/14/2004 | CN1157355C Novel ester compound and themrosetting resin composition using the same |
| 07/13/2004 | US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/13/2004 | CA2155020C Antiviral naphthoquinone compounds, compositions and uses thereof |
| 07/08/2004 | WO2004056792A1 An organic extract of ginkgo, and the preparation method and use thereof |
| 07/08/2004 | WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004045511A3 Non-steroidal farnesoid x receptor modulators |
| 07/08/2004 | WO2004029578A3 Energy transfer dyes, terminators and use thereof |
| 07/08/2004 | US20040132805 preferably also contains a compound that donates, transfers, releases or induces production of nitric oxide and a hydralazine antioxidant; for treating and/or preventing a vascular disease characterized by nitric oxide insufficiency |
| 07/08/2004 | US20040131749 extraction of anthocyanins or flavonoids, for use as anticarcinogenic, antidiabetic, antiinflammatory, anticholesterol, hyportensive agents, or prophylaxis of cardiovascular disorders or as dietetics |
| 07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/07/2004 | EP1307586B1 Enzyme substrate |
| 07/07/2004 | CN1511147A Synthesis of cannabinoids |
| 07/07/2004 | CN1511130A Uncatalysed addition reactions |
| 07/07/2004 | CN1156466C Process for preparing 3-isochromanone |
| 07/07/2004 | CN1156465C Extraction technology of new stellerin A |
| 07/01/2004 | WO2004054995A1 New alpha-glucosidase inhibitors and their synthesis from a natural source |
| 07/01/2004 | WO2004054994A1 A process for the preparation of (-)-epicatechin from a new natural source namely dichrostachys cinerea |
| 07/01/2004 | WO2004054993A1 A new antioxidant from natural source |
| 07/01/2004 | WO2004054572A2 Novel benzopyran analogs and their use for the treatment of glaucoma |
| 07/01/2004 | WO2004019874A3 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
| 07/01/2004 | US20040127576 Estrogen receptor modulators |
| 07/01/2004 | US20040127572 the prevention or amelioration of sleep-related breathing disorders such as sleep apnea |
| 07/01/2004 | US20040126443 Method for producing composition containing soluble isoflavones |
| 07/01/2004 | CA2506204A1 Novel benzopyran analogs and their use for the treatment of glaucoma |
| 06/30/2004 | EP1432734A1 Cytokine receptor |
| 06/30/2004 | EP1432696A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 06/30/2004 | EP1432695A1 A process for the stereoselective synthesis of 2-hydroxymethyl-chromans |
| 06/30/2004 | EP1432694A1 Stereospecific process for the synthesis of 2-yl chroman derivatives |
| 06/30/2004 | EP1432677A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 06/30/2004 | EP1432453A1 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 06/30/2004 | EP1432312A1 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues |
| 06/30/2004 | EP0939630B1 Use of benzopyranols to treat neurological disorders |
| 06/30/2004 | EP0822825B1 Ginkgo biloba flavonoid extract which is terpene-free and has a high flavonoid heteroside content |
| 06/30/2004 | CN1509182A Use of extracts and preparations from iris plants and tectorigenin as organ selective medicament for treating urethra disease |
| 06/30/2004 | CN1155655C Epoxy resin composition |
| 06/30/2004 | CN1155592C Process for preparing total jujuboflavone with calmative and hypnosis action |
| 06/30/2004 | CN1155591C Prepn of baicalin |
| 06/30/2004 | CN1155590C Chromone compounds with antineoplastic activity and its open-loop products and preparing process |
| 06/30/2004 | CN1155589C Compounds and methods for modulation of estroglen receptors |
| 06/30/2004 | CN1155558C N-alkoxyalkyl-N, N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 06/29/2004 | US6756403 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
| 06/29/2004 | US6756378 VLA-4 inhibitor compounds |
| 06/29/2004 | US6756231 A rhodamine derivative useful as a reagent for measurement of nitric oxide |
| 06/29/2004 | US6756209 7-Alkoxycoumarins as CYP2C9 substrates and activity assay |
| 06/29/2004 | CA2133089C Novel cyclic amino acids and derivatives thereof |
| 06/24/2004 | WO2004052873A2 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents |
| 06/24/2004 | WO2004017922A3 Keto cannabinoids with therapeutic indications |
| 06/24/2004 | WO2004010931A3 Color-stable, low impurity tocopherol compositions and processes for preparing the same |
| 06/24/2004 | WO2003103583A3 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2002092594A8 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 06/24/2004 | US20040122085 Compounds based on 1-oxoisochroman or - phthalan such as phyllodulcin and hydrangenol; food, beverage and feed additives; alcohol abuse |
| 06/24/2004 | US20040122057 Novel mandelic acid derivatives |
| 06/24/2004 | US20040122001 Pharmaceutical compounds |
| 06/24/2004 | US20040121059 ultrafiltration process and a liquid-liquid extraction without the need for additional extraction or purification steps; daidzin, genistin, glycitin; molasses |
| 06/24/2004 | DE10249324A1 Polymerisationsfähige bicyclische Cyclopropanderivate und deren Verwendung zur Herstellung von Dentalmaterialien Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials |
| 06/24/2004 | CA2508020A1 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1429750A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 06/23/2004 | EP0973516B1 Use of halo and/or nitro-substituted flavonoids as anxyolitics |